Trial Profile
Efficacy and Long-Term Safety of SK-0403 as Monotherapy in Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2016
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Kowa
- 24 May 2016 New trial record